IBIO, INC. Current Assets
IBIO, INC. (IBIO) had Current Assets of $92.22 million as of 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-28
- 2026-06-30: Assets, Current $92.22M.
- 2026-03-31: Assets, Current $77.25M.
- 2025-12-31: Assets, Current $53.37M.
- 2025-09-30: Assets, Current $50.77M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $92.22M 10-K · filed 2026-08-28 | |
| 2026-03-31 | $77.25M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $53.37M 10-Q · filed 2026-02-10 | |
| 2025-09-30 | $50.77M 10-Q/A · filed 2025-11-17 | |
| 2025-06-30 | $9.72M 10-K · filed 2026-08-28 | |
| 2025-03-31 | $6.06M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $8.29M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $11.71M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $15.67M 10-K · filed 2025-09-05 | |
| 2024-03-31 | $36.14M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $19.70M 10-Q · filed 2024-02-09 | |
| 2023-09-30 | $23.02M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $26.26M 10-K/A · filed 2024-09-24 | |
| 2023-03-31 | $27.09M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $38.23M 10-Q/A · filed 2023-05-19 | |
| 2022-09-30 | $63.56M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $45.07M 10-K · filed 2023-09-27 | |
| 2022-03-31 | $60.32M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $67.50M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $89.82M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $104.60M 10-K · filed 2022-10-11 | |
| 2021-03-31 | $107.20M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $110.88M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $84.96M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $61.75M 10-K · filed 2021-09-28 | |
| 2020-03-31 | $10.30M 10-K · filed 2020-10-13 | |
| 2019-12-31 | $4.01M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $2.36M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $4.81M 10-K · filed 2020-10-13 | |
| 2019-03-31 | $9.59M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $13.97M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $16.34M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $16.29M 10-K · filed 2019-08-26 | |
| 2018-03-31 | $3.99M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $7.82M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $6.38M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $8.57M 10-K · filed 2018-09-18 | |
| 2017-03-31 | $12.98M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $16.75M 10-Q · filed 2017-02-21 | |
| 2016-09-30 | $20.46M 10-Q · filed 2016-11-18 | |
| 2016-06-30 | $23.91M 10-K · filed 2017-09-15 | |
| 2016-03-31 | $22.72M 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $7.20M 10-Q · filed 2016-02-22 | |
| 2015-09-30 | $9.08M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $10.12M 10-K · filed 2016-10-13 | |
| 2015-03-31 | $9.04M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $8.56M 10-Q · filed 2015-02-24 | |
| 2014-09-30 | $4.12M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $3.91M 10-K · filed 2015-10-13 | |
| 2014-03-31 | $5.53M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $6.94M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $4.64M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $6.63M 10-K · filed 2014-09-29 | |
| 2013-03-31 | $2.21M 10-Q · filed 2013-05-20 | |
| 2012-12-31 | $4.00M 10-Q · filed 2013-02-19 | |
| 2012-09-30 | $5.15M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $6.90M 10-K/A · filed 2013-10-04 | $6.90M 10-K/A · filed 2012-10-15 |
| 2012-03-31 | $7.68M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.94M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $2.53M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $4.30M 10-K/A · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |